UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000017824 |
|---|---|
| Receipt number | R000020645 |
| Scientific Title | A study for evaluating the effect of the intake of an indigestible dextrin-containing beverage on postprandial increase in Serum Triglyceride : randomized, placebo-controlled, double blind cross-over trial |
| Date of disclosure of the study information | 2015/06/05 |
| Last modified on | 2016/02/18 19:48:06 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study for evaluating the effect of the intake of an indigestible dextrin-containing beverage on postprandial increase in Serum Triglyceride : randomized, placebo-controlled, double blind cross-over trial
Acronym
A study for evaluating the effect of the intake of indigestible dextrin-containing beverage on postprandial increase in Serum Triglyceride
Scientific Title
A study for evaluating the effect of the intake of an indigestible dextrin-containing beverage on postprandial increase in Serum Triglyceride : randomized, placebo-controlled, double blind cross-over trial
Scientific Title:Acronym
A study for evaluating the effect of the intake of indigestible dextrin-containing beverage on postprandial increase in Serum Triglyceride
Region
| Japan |
Condition
Condition
Healthy adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the effect of an indigestible dextrin-containing beverage on postprandial increase in Serum Triglyceride
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
area under the curve for serum triglyceride levels
Key secondary outcomes
fasting triglyceride level, triglyceride level of 2,3,4 and 6hours after the high-fat meal ingestion, Remnant-like particle cholesterol
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
test beverage containing of indigestible dextrin
Interventions/Control_2
placebo beverage without indigestible dextrin
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 64 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
(1) Males and females from 20 to 64 years of age
(2) fasting triglyceride levels
are ranged from 120 mg/dL to 199 mg/dL
Key exclusion criteria
(1) Subjects who routinely use food containing of indigestible dextrin
(2) Subjects routinely taking medicine or health food which may influence lipid metabolism
(3) Subjects who are under medication or having a history of serious diseases for which medication was required
(4) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease)
(5) Subjects having possibilities for emerging allergy related to the study
(6) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination
(7) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study
(8) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating
(9) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire
(10) Subjects judged as unsuitable for the study by the investigator for other reasons
Target sample size
90
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | 1) Sumio Kondo, 2)Kumie Ito |
Organization
1)Medical Corporation Kensho-kai,Fukushima Healthcare Center
2)Yaesu Sakuradori Clinic
Division name
1)Internal Medicine, Department of Neurosurgery 2)Internal Medicine
Zip code
Address
1) 2-12-16 tamagawa,fukushima-ku,osaka-shi,Osaka,553-0004,Japan 2)1-6-6yaesu,chuo-ku,Tokyo,Japan
TEL
06-6441-6848.03-6214-1285
ko283434@ares.eonet.ne.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Chiharu Goto |
Organization
TTC Co.,Ltd
Division name
Clinical Research Planning Department
Zip code
Address
Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo
TEL
03-5459-5329
Homepage URL
c.goto@ttc-tokyo.co.jp
Sponsor or person
Institute
TTC Co.,Ltd.
Institute
Department
Personal name
Funding Source
Organization
Coca Cola (Japan) Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 06 | Month | 05 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 05 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 06 | Month | 06 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Principal investigator's E-mail adress 2):info@y-sakuradoori.jp
Management information
Registered date
| 2015 | Year | 06 | Month | 05 | Day |
Last modified on
| 2016 | Year | 02 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020645
